Dr. Halloran is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Jefferson Med Coll-Thos Jefferson Univ
Philadelphia, PA 19019
Education & Training
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2016
Certifications & Licensure
- PA State Medical License 2016 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 12 citationsTargeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma.Clemens Krepler, Min Xiao, Minu Samanta, Adina Vultur, Hsin-Yi Chen
Oncotarget. 2016-09-17 - 94 citationsBRAF Inhibition Stimulates Melanoma-Associated Macrophages to Drive Tumor GrowthTao Wang, Min Xiao, Yingbin Ge, Clemens Krepler, Eric Belser
Clinical Cancer Research. 2015-04-01 - 126 citationsPLX4032, a potent inhibitor of the B-Raf V600E oncogene, selectively inhibits V600E-positive melanomas.John T. Lee, Ling Li, Patricia Brafford, Marcia van den Eijnden, Molly B. Halloran
Pigment Cell & Melanoma Research. 2010-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: